Suzhou BioBAY drives $26.6B in overseas biopharma deals in Jan-May
The growth is fueled by high-value strategic partnerships and the park’s focus on proprietary intellectual property.
Tag: biotech
Read More
Junhemeng Biopharma bags nearly $29 million in Series C funding
The company says its approach helps reduce manufacturing risks that often emerge during large-scale production.